Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000289703 represents a novel RNA transcript located on the sense (coding) strand within an intron of the EFL1 gene. The functional relevance of such transcripts is largely uncharacterized; they are often annotated through high-throughput sequencing initiatives and may arise from alternative splicing, cryptic promoter activity, or transcriptional noise[1][3][5]. Most novel transcripts identified in recent transcriptomic surveys are expressed at low levels and are less conserved evolutionarily, suggesting they may not have major cellular roles[3][5]. While some sense intronic or intergenic transcripts have been shown to possess regulatory functions, such a role for ENSG00000289703 is not established. It is not considered a conventional therapeutic target nor associated with drugs or disease processes at this time[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to EFL1 (ENSG00000289703).